These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31795759)

  • 1. Assessing metacognitive and help-seeking strategies in schizophrenia: design and psychometric validation of the Versailles Metacognitive Strategies Evaluation Questionnaire.
    Brunet-Gouet E; Urbach M; Ramos V; Ehrminger M; Aouizerate B; Brunel L; Capdevielle D; Chereau I; Dubertret C; Dubreucq J; Fond G; Lançon C; Leignier S; Mallet J; Misdrahi D; Pires S; Schneider P; Schürhoff F; Yazbek H; Zinetti-Bertschy A; Bazin N; Passerieux C; Roux P
    Clin Rehabil; 2020 Feb; 34(2):263-275. PubMed ID: 31795759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychometric approach of metacognition: Pilot study in clinical population].
    Visinet A; Soumet-Leman C; Baptista A; Bungener C; Jouvent R
    Encephale; 2017 Apr; 43(2):120-127. PubMed ID: 27349578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the French version of the « Meta-Cognition Questionnaire » for adolescents (MCQ-Af): Evolution of metacognitive beliefs with age and their links with anxiety during adolescence.
    Lachat Shakeshaft Y; Lecerf T; Morosan L; Badoud DM; Debbané M
    PLoS One; 2020; 15(3):e0230171. PubMed ID: 32160251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of worry: validation of a French translation of the Penn State Worry Questionnaire].
    Gosselin P; Dugas MJ; Ladouceur R; Freeston MH
    Encephale; 2001; 27(5):475-84. PubMed ID: 11760697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics and impact of metacognitive deficits in schizophrenia].
    Quiles C; Prouteau A; Verdoux H
    Encephale; 2013 Apr; 39(2):123-9. PubMed ID: 23219408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between metacognitive beliefs and psychosocial performance in at-risk states of psychosis and patients with first psychotic episodes.
    Brüne M; Drommelschmidt KA; Krüger-Özgürdal S; Juckel G
    Early Interv Psychiatry; 2019 Jun; 13(3):604-612. PubMed ID: 29314591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A preliminary validation of a new French instrument to assess quality of life for caregivers of patients suffering from schizophrenia].
    Richieri R; Boyer L; Reine G; Loundou AD; Simeoni MC; Auquier P; Lançon C
    Encephale; 2011 Dec; 37(6):425-32. PubMed ID: 22137214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breaking the cycle: Exploring the relationship of metacognition beliefs, obsessive-compulsive symptoms, and psychosocial performance among individuals diagnosed with schizophrenia.
    Taha SM; El-Sayed MM; Khedr MA; El-Ashry AM; Aboeldahab M; Sonbol HM; Abd-Elhay ES
    J Psychiatr Ment Health Nurs; 2024 Jul; ():. PubMed ID: 39022886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight across mental disorders: A multifaceted metacognitive phenomenon.
    Konstantakopoulos G
    Psychiatriki; 2019; 30(1):13-16. PubMed ID: 31115349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and psychometric properties of a new brief scale for subjective personal agency (SPA-5) in people with schizophrenia.
    Yamaguchi S; Shiozawa T; Matsunaga A; Bernick P; Sawada U; Taneda A; Osumi T; Fujii C
    Epidemiol Psychiatr Sci; 2020 Apr; 29():e111. PubMed ID: 32272978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metacognitive functioning in individuals at clinical high risk for psychosis.
    Barbato M; Penn DL; Perkins DO; Woods SW; Liu L; Addington J
    Behav Cogn Psychother; 2014 Sep; 42(5):526-34. PubMed ID: 23517866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The developmental origins of metacognitive deficits in schizophrenia.
    Aydin O; Balikci K; Tas C; Aydin PU; Danaci AE; Brüne M; Lysaker PH
    Psychiatry Res; 2016 Nov; 245():15-21. PubMed ID: 27526312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Short Version of the Metacognitive Anger Processing Scale (MAP-SV) - initial psychometric testing.
    Moeller SB; Juul S; Arendt ITP
    Behav Cogn Psychother; 2022 Jan; 50(1):117-121. PubMed ID: 34078508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Fear of Negative Evaluation scale (FNE): psychometric properties of the French version].
    Musa C; Kostogianni N; Lépine JP
    Encephale; 2004; 30(6):517-24. PubMed ID: 15738853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric validation of the French self and proxy versions of the PedsQL™ 4.0 generic health-related quality of life questionnaire for 8-12 year-old children.
    Amedro P; Huguet H; Macioce V; Dorka R; Auer A; Guillaumont S; Auquier P; Abassi H; Picot MC
    Health Qual Life Outcomes; 2021 Mar; 19(1):75. PubMed ID: 33663527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metacognitive beliefs in depressed in-patients: adaptation and validation of the short version of the Metacognitions Questionnaire (MCQ-30) for French clinical and non-clinical samples.
    Baptista A; Soumet-Leman C; Visinet A; Jouvent R
    Behav Cogn Psychother; 2020 Jul; 48(4):498-502. PubMed ID: 32522308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Craniofacial pain and disability inventory (CF-PDI): development and psychometric validation of a new questionnaire.
    La Touche R; Pardo-Montero J; Gil-Martínez A; Paris-Alemany A; Angulo-Díaz-Parreño S; Suárez-Falcón JC; Lara-Lara M; Fernández-Carnero J
    Pain Physician; 2014; 17(1):95-108. PubMed ID: 24452650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric evaluation of the patient-reported experience of cognitive impairment in schizophrenia (PRECIS) scale.
    Lenderking WR; Atkinson MJ; Ladd MK; Savva Y; Sommer S; Sidovar M; Hastedt C
    J Patient Rep Outcomes; 2024 Jun; 8(1):61. PubMed ID: 38884842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Serbian version of the Metacognitions Questionnaire-30 in nonclinical and clinical samples.
    Marković V; Purić D; Vukosavljević-Gvozden T; Begović A
    Clin Psychol Psychother; 2019 Jul; 26(4):458-470. PubMed ID: 30893490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.